Trial Profile
Research of Aldosterone Breakthrough by Aliskiren
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Valsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 30 Dec 2011 New trial record